Suppr超能文献

绝经及激素替代疗法对吡啶交联物尿排泄的影响。

Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links.

作者信息

Uebelhart D, Schlemmer A, Johansen J S, Gineyts E, Christiansen C, Delmas P D

机构信息

INSERM Unit 234, Hôpital E. Herriot, Lyon, France.

出版信息

J Clin Endocrinol Metab. 1991 Feb;72(2):367-73. doi: 10.1210/jcem-72-2-367.

Abstract

Pyridinoline (Pyr) and deoxypyridinoline (D-Pyr) are two cross-links of collagen molecules that are present in the extracellular matrix and released during its degradation. In contrast to the wide distribution of collagen, Pyr is present in bone and cartilage, but not in significant amounts in other connective tissues, and D-Pyr appears to be specific for bone tissue. Therefore, the urinary excretion of Pyr and D-Pyr might be a sensitive marker of bone matrix degradation. Using a specific high pressure liquid chromatography assay we have measured Pyr and D-Pyr cross-links in a 24-h and a fasting urine sample in 60 early postmenopausal women and 19 premenopausal women matched for age. Menopause induced a 62% increase in Fu Pyr (49.8 +/- 18.7 vs. 30.8 +/- 8.0 pmol/mumol creatinine; P less than 0.001) and an 82% increase in Fu D-Pyr (8.2 +/- 3.4 vs. 4.5 +/- 1.4 pmol/mumol creatinine; P less than 0.001). In 20 postmenopausal women on hormone replacement therapy, urinary Pyr and D-Pyr returned to premenopausal levels within 6 months, contrasting with unchanged levels during placebo treatment. The 24-h excretion of Pyr and D-Pyr was significantly lower than the fasting excretion, but was similarly decreased after hormone replacement therapy. Pyr and D-Pyr excretion measured in the same urinary sample were highly correlated (r = 0.85 for fasting and 0.83 for 24-h sampling), but correlations between fasting and 24-h values were weak (D-Pyr, r = 0.30; Pyr, r = 0.29; P less than 0.05 for both). Correlations between urinary cross-links and other markers of bone turnover (Fu hydroxyproline/creatinine and plasma osteocalcin) were significant but low (Pyr vs. osteocalcin, r = 0.29, P less than 0.05; Pyr vs. hydroxyproline, r = 0/.34; P less than 0.01; D-Pyr vs. osteocalcin, r = 0.39; P less than 0.01), except for D-Pyr vs. hydroxyproline (r = 0.24; P = 0.07), suggesting that these markers reflect different events of bone metabolism. Finally, a single measurement of the fasting excretion, but not of the 24-h excretion, of cross-links was significantly correlated (Pyr, r = 0.34; P less than 0.05; D-Pyr, r = -0.46; P less than 0.01), with the subsequent spontaneous rate of bone loss assessed by repeated measurements of the radial bone mineral content in 37 postmenopausal women.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

吡啶啉(Pyr)和脱氧吡啶啉(D-Pyr)是胶原蛋白分子的两种交联物,存在于细胞外基质中,并在其降解过程中释放出来。与广泛分布的胶原蛋白不同,Pyr存在于骨骼和软骨中,但在其他结缔组织中含量不高,而D-Pyr似乎对骨组织具有特异性。因此,尿中Pyr和D-Pyr的排泄可能是骨基质降解的敏感标志物。我们使用特定的高压液相色谱分析法,对60名绝经后早期女性和19名年龄匹配的绝经前女性的24小时尿液样本和空腹尿液样本中的Pyr和D-Pyr交联物进行了测量。绝经导致尿游离Pyr增加62%(49.8±18.7对30.8±8.0 pmol/μmol肌酐;P<0.001),尿游离D-Pyr增加82%(8.2±3.4对4.5±1.4 pmol/μmol肌酐;P<0.001)。在20名接受激素替代疗法的绝经后女性中,尿中Pyr和D-Pyr在6个月内恢复到绝经前水平,这与安慰剂治疗期间水平不变形成对比。Pyr和D-Pyr的24小时排泄量显著低于空腹排泄量,但在激素替代疗法后同样降低。在同一尿液样本中测量的Pyr和D-Pyr排泄量高度相关(空腹时r=0.85,24小时采样时r=0.83),但空腹值与24小时值之间的相关性较弱(D-Pyr,r=0.30;Pyr,r=0.29;两者P<0.05)。尿交联物与其他骨转换标志物(尿游离羟脯氨酸/肌酐和血浆骨钙素)之间的相关性显著但较低(Pyr与骨钙素,r=0.29,P<0.05;Pyr与羟脯氨酸,r=0.34;P<0.01;D-Pyr与骨钙素,r=0.39;P<0.01),除了D-Pyr与羟脯氨酸(r=0.24;P=0.07),这表明这些标志物反映了骨代谢的不同事件。最后,在37名绝经后女性中,通过重复测量桡骨矿物质含量评估的骨丢失自发率与单次空腹排泄的交联物测量值显著相关(Pyr,r=0.34;P<0.05;D-Pyr,r=-0.46;P<0.01)。(摘要截取自400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验